Bisaf Strep A Self-Test from Altruan GmbH remains active in recall status after the FDA flagged lack of clearance. The Class II medical device was distributed nationwide in the United States. The hazard is lack of FDA clearance. Consumers should stop use immediately and follow manufacturer guidance.
Product not cleared by the FDA.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Altruan GmbH or your healthcare provider for instructions. Notification method: Other
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The Bisaf Strep A Self-Test is a home or point-of-care throat swab test intended to detect group A streptococcal antigens. It is marketed for rapid results and convenience.
The hazard is regulatory rather than a device defect. Without FDA clearance, there is regulatory risk and potential questions about performance and reliability.
This recall is not described as part of a broader industry pattern in the provided data.
Consumers should stop using the device to avoid potential regulatory or performance concerns. No injuries reported yet.
Look on the device packaging for model and batch information.
Refunds or replacements timelines are not specified in the summary; follow manufacturer guidance and FDA updates.
Keep packaging, model and batch information, and recall notices for future reference.
Product: Bisaf Strep A Self-Test. Purpose: Detection of group A streptococcal antigens in throat swabs. Quantity: 188 units. Distribution: US nationwide. Manufacturer: Altruan GmbH. Model No.: AL-42153. Lot Code: 6952804827274. UDI: No UDI.
No injuries or incidents have been reported in the provided data.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
ZOLIQUEX recalled adult portable bed rails sold on Amazon after reports of entrapment and asphyxiation risk. The recall targets silver bed rails measuring 12.4 inches wide by 33.07 inches tall and weighing 7.1 pounds. The model numbers ZEX014-V1 and the Zoliquex branding appear on packaging. Stop using the product and seek a full refund by contacting ZOLIQUEX.
Vitaquest International recalled Arey Not Today iron supplements sold at retailers nationwide after determining the products do not meet the Poison Prevention Packaging Act's child-resistant packaging requirement. The noncompliant packaging creates a poisoning risk to young children if ingested. Consumers should stop using the products immediately and contact Vitaquest for a free child-resistant替换
Easymake adult portable bed rails imported by ZFZG-US are recalled on April 9, 2026. The recall cites a risk of entrapment and asphyxiation and notes the product lacks required hazard warning labels. Stop using the recalled rails immediately and contact ZFZG-US for a full refund.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Sangohe expands its 2026 recall of adult portable bed rails 504E and 504Q due to entrapment and asphyxiation risk. The recall cites noncompliance with the mandatory standard and missing warning labels. Stop using the recalled rails and pursue a full refund by contacting Sangohe.
Tuymec Minoxidil Hair Growth Kit sold on Amazon by DrHealBeauty is recalled for non-child-resistant packaging. The kit contains two black spray bottles with 5% minoxidil and BIOTIN labels. Consumers should stop using the product immediately and contact DrHealBeauty for a free empty replacement bottle with a child-resistant closure.
TecFlox recalled its Minoxidil Topical Solution hair growth serum bottles on April 2, 2026. The packaging is not child-resistant, violating the Poison Prevention Packaging Act. Consumers should stop using the product immediately, store it out of reach of children, and email TecFloxrecall@outlook.com to receive free replacement bottles. Only bottles with serum remaining will be replaced; dispose of
K.C. Pharmaceuticals recalled eight OTC eye drops sold nationwide under CVS Health, Walgreens and Kroger brands after sterility could not be verified. The recall covers all lots within expiry through Oct 31, 2026. Nonsterile eye drops can harbor bacteria and fungus, causing serious infections that may lead to vision loss. Stop using recalled products and return them for a full refund at the store.